# Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC

> **NCT06815679** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Università degli Studi di Ferrara** · enrollment: 20 (estimated)

## Conditions studied

- Acute Respiratory Failure
- Pneumonia

## Interventions

- **DRUG:** salbutamol 2.5 mg via vibrating mesh nebulizer (VMN)

## Key facts

- **NCT ID:** NCT06815679
- **Lead sponsor:** Università degli Studi di Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-01
- **Final completion:** 2026-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06815679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06815679, "Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06815679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*